Aggravation vs. Exacerbation: How Pharmacy Records Prove Which One Happened

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | August 5, 2024 | 10 min read

Aggravation means permanent worsening. Exacerbation means a temporary flare-up. The distinction can mean the difference between a six-figure settlement and a five-figure nuisance payment. Learn how pharmacy fill records establish which occurred, and how to present this evidence to maximize case value.

Aggravation vs. Exacerbation: How Pharmacy Records Prove Which One Happened

In personal injury litigation, few legal distinctions have more impact on case value than the difference between aggravation and exacerbation of a pre-existing condition. Aggravation means the accident permanently worsened the plaintiff's condition -- the plaintiff's baseline shifted upward permanently, and they will never return to where they were before the accident. Exacerbation means the accident caused a temporary flare-up -- the plaintiff's condition worsened for a period but ultimately returned (or will return) to the pre-accident baseline.

Defense counsel fights hard to characterize every pre-existing condition as exacerbated, not aggravated. The difference in damages can be enormous. Future medical expenses, future pain and suffering, and future medication costs are recoverable in aggravation cases but not in exacerbation cases. In a high-stakes case involving a plaintiff with chronic pain, the aggravation vs. exacerbation distinction can add six figures to the damages calculation.

Pharmacy fill records are one of the most objective, contemporaneously created pieces of evidence for resolving this dispute. Here is how to use them.

[!KEY] The aggravation vs. exacerbation distinction can add six figures to a damages calculation — a medication that first appears after the accident date and is still being filled at the time of demand or trial is among the most objective evidence that the plaintiff's clinical baseline shifted permanently.

Defining the Terms Precisely

Aggravation refers to a permanent increase in the severity of a pre-existing condition caused by the accident. After a true aggravation, the plaintiff's baseline condition is worse than it was before the accident and will remain so indefinitely. The plaintiff will require more medical care, more medication, and will experience greater limitations in daily function than they would have absent the accident.

Exacerbation refers to a temporary worsening of a pre-existing condition. The plaintiff's symptoms increase for a period -- days, weeks, or months -- but eventually return to approximately the pre-accident baseline. Once the exacerbation resolves, the plaintiff is not materially worse off than before the accident.

The practical legal question is: at the time of trial or settlement, has the plaintiff returned to baseline -- or have they established a new, worse baseline that reflects permanent aggravation?

Why Pharmacy Records Are Particularly Reliable Evidence

Clinical notes can be subjective. Patient pain ratings are inherently subjective. Imaging findings are open to interpretation. But pharmacy fill records are contemporaneous, objective, and specific: on this date, this physician prescribed this medication at this dose, and the patient filled it at this pharmacy.

A pre-accident medication regimen is a documented clinical baseline. Post-accident medication changes are documented responses to changed clinical circumstances. The trajectory of those changes over time tells the aggravation-versus-exacerbation story more objectively than any other source.

[!KEY] Pharmacy fill records are among the most objective evidence available for proving aggravation — unlike clinical notes or pain ratings, a fill date, dose, and drug name are not subject to interpretation and cannot be explained away as patient-reported subjectivity.

What pure exacerbation looks like in the pharmacy record:

• Post-accident medication additions or dose increases that gradually step down over weeks to months
• A medication regimen that, after six to twelve months, is substantially similar to the pre-accident regimen
• Short-term additions (acute pain medications, short-course steroids) that are not renewed beyond the acute treatment phase
• No new long-term medication classes introduced that remain active through the end of treatment

What aggravation looks like in the pharmacy record:

• New medication classes introduced post-accident that remain active indefinitely (e.g., a neuropathic agent like pregabalin or gabapentin started after the accident that has not been discontinued)
• Dose escalations in pre-existing medications that never returned to pre-accident levels
• Long-term opioid prescribing initiated after the accident in a plaintiff who had no prior opioid history
• Progressive complexity of the medication regimen over time rather than simplification

The most powerful aggravation evidence is a medication that appears for the first time after the accident date and is still being filled at the time of demand, trial, or settlement. That trajectory -- introduction post-accident, continued fills, no discontinuation -- is direct evidence that the plaintiff's clinical condition now requires ongoing pharmacological management that it did not require before.

[!TIP] Obtain pre-accident pharmacy records going back at least 24 months before building the medication timeline — a plaintiff who was on a stable two-medication regimen for 18 months before the accident presents the clearest aggravation narrative when they are on five medications at the time of demand.

Building the Medication Timeline

The core evidentiary tool is a medication timeline that runs from two to three years before the accident to the present day. For each medication in the post-accident regimen, the timeline should document:

1. Pre-accident status: Was this medication in the pre-accident regimen? At what dose?
2. Introduction date: If new, when was it first prescribed and filled relative to the accident?
3. Dose trajectory: Did the dose increase, stay stable, or decrease over time?
4. Current status: Is the medication still being filled? At what dose?

Presenting this timeline in a demand package or at trial answers the aggravation-versus-exacerbation question with documented, objective evidence rather than competing expert opinions.

Example Medication Timeline Analysis

Consider a plaintiff with a pre-accident history of low back pain managed with:

• Naproxen 500mg twice daily (filled consistently for 18 months pre-accident)
• Cyclobenzaprine 5mg as-needed (filled intermittently pre-accident)

Post-accident pharmacy record shows:

• Naproxen dose increased to 500mg three times daily (plus omeprazole added for GI protection)
• Cyclobenzaprine 10mg at bedtime (higher dose, now nightly rather than as-needed)
• Tramadol 50mg twice daily -- new medication, first fill 10 days post-accident
• Gabapentin 300mg three times daily -- new medication, first fill 3 weeks post-accident
• Tizanidine 4mg at bedtime -- new medication, first fill 6 weeks post-accident

If, at 24 months post-accident, the plaintiff is still taking gabapentin, tramadol remains in the regimen, and the naproxen dose has not returned to its pre-accident level -- that is documented aggravation. The pre-accident two-medication regimen has become a five-medication regimen with higher doses across the board, and the trajectory shows no return to baseline.

Expert Witness Use of Pharmacy Records

A pharmacist expert witness or a clinical pharmacist providing a MERIT report can present this timeline analysis in a format understandable to adjusters, mediators, and juries. The key opinions a pharmacist expert can offer include:

• Whether each post-accident medication is clinically consistent with the injury mechanism (countering defense arguments that medications are unrelated to the accident)
• Whether the medication trajectory is consistent with aggravation or exacerbation (the core opinion that determines case value)
• Whether the current medication regimen is the minimum clinically necessary (countering overtreatment arguments)
• What future medication costs can be projected based on the current regimen assuming continued aggravation

For high-value cases with life care plan components, a pharmacist expert's projection of lifetime medication costs -- tied to the documented aggravation of the pre-existing condition -- is essential for maximizing the damages case.

Defense Tactics and How to Counter Them

"The plaintiff returned to their pre-accident medication regimen."

If defense can show the plaintiff's current regimen is substantially similar to the pre-accident regimen, they support an exacerbation characterization. Counter this by identifying specific medications that were not in the pre-accident regimen, or by documenting that pre-existing medications are now prescribed at higher doses or with more frequency.

"The added medications are for pre-existing conditions, not the accident."

Defense will hire an IME physician to opine that gabapentin was started for pre-existing diabetic neuropathy, or that the opioid was added for a prior surgery, not for accident-related pain. Counter this with: (1) the timing of introduction relative to the accident; (2) the treating physician's clinical notes explaining the indication; (3) pharmacist expert testimony on the clinical appropriateness of each medication for accident-related injury.

"Any aggravation would have occurred anyway given the plaintiff's prior trajectory."

Defense experts sometimes argue that the pre-existing condition was already worsening before the accident, and the plaintiff would have arrived at the current medication regimen regardless. Counter this by documenting the pre-accident stability of the medication regimen. A plaintiff who was on a stable two-medication regimen for 18 months before the accident is not on a trajectory toward the five-medication post-accident regimen -- the accident changed the trajectory.

"Maximum medical improvement has been reached and no further aggravation-related damages are recoverable."

Maximum medical improvement (MMI) is the point at which no further significant recovery is expected. Defense uses MMI to cut off future damages arguments. Counter this by showing that the current medication regimen -- established after the accident and representing a permanent increase in pharmacological management complexity -- is itself evidence of permanent aggravation. MMI does not mean the plaintiff has returned to baseline; it means they have plateaued at a new, worse baseline.

Documenting Future Medication Costs in Aggravation Cases

When aggravation is established, future medication costs are recoverable. Calculating these costs requires:

[!KEY] In high-value aggravation cases involving expensive specialty medications — CGRP inhibitors, long-term neuropathic agents, spasticity drugs — engage a pharmacist expert to project lifetime costs; these projections are frequently underestimated by attorneys unfamiliar with specialty drug pricing and can add six figures to the damages calculation.

1. Current medication regimen -- documented in pharmacy records
2. Life expectancy -- from standard actuarial tables, plaintiff's age at injury
3. Per-medication annual cost -- based on current fill records and pharmacy pricing
4. Escalation assumptions -- accounting for expected drug price increases over time

A pharmacist expert can provide this calculation with professional opinion backing. For cases involving expensive specialty medications -- CGRP inhibitors for post-traumatic migraine, spasticity medications for spinal cord aggravation, or long-term neuropathic agents -- the lifetime cost projection can be substantial and is often underestimated by attorneys unfamiliar with specialty drug pricing.

Practical Checklist for Attorneys

• Obtain pre-accident pharmacy records going back at least 24 months
• Obtain post-accident pharmacy records through the current date
• Identify all medications in the current regimen that were not in the pre-accident regimen
• For each new medication, confirm the first fill date relative to the accident date
• For pre-existing medications, compare pre-accident and post-accident doses
• Build a written medication timeline and have the treating physician or pharmacist review it
• Order a MERIT report if the case involves significant medication changes
• In high-value cases with aggravation claims, engage a pharmacist expert for future cost projections

LienScripts provides complete pharmacy records management, MERIT reports, and pharmacist expert witness services for personal injury attorneys. Contact us to discuss how pharmacy documentation can establish the aggravation component of your cases.

Related Resources

• Eggshell Skull Rule and Pre-Existing Medication History -- Using pre-existing medication history to support eggshell claims
• What Is a MERIT Report? -- Pharmacist clinical narratives for damages documentation
• Pharmacy Records as Causation Evidence at Trial -- Expert testimony and documentary evidence
• What Is Maximum Medical Improvement? -- How MMI intersects with aggravation damages
• Life Care Plan Pharmacy Costs for PI Attorneys -- Projecting future medication costs in catastrophic injury cases